[27J-am] Drug delivery system in oncotherapy-1

Sun. Mar 27, 2022 9:30 AM - 10:42 AM [Room J] Conference Room 223 (Bldg. 2: 2F)

Chair: Kentaro Kogure

+Add all to schedule

9:30 AM - 9:42 AM

[27J-am01S] Study on the antitumor effect of extracellular vesicles derived from reovirus-infected cancer cells

○Naomi Shuwari¹, Chieko Inoue², Kentarou Jingushi^1,2, Kazutake Tsujikawa^1,2, Hiroyuki Mizuguchi^1,2,3,4,5, Fuminori Sakurai^1,2 (1. Pharm. Sci., Osaka Univ., 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. MEI cent., Osaka Univ., 5. OTRI, Osaka Univ)

9:42 AM - 9:54 AM

[27J-am02S] Elucidating the mechanism of the anti-tumor effects mediated by novel oncolytic adenovirus based on serotype 35.

○Ryosuke Ono¹, Kosuke Takayama¹, Fuminori Sakurai¹, Hiroyuki Mizuguchi^1,2,3,4 (1. Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University,, 2. Laboratory of Hepatocyte Regulation, National Institute of Biomedical Innovation, Health and Nutrition, 3. Global Center for Medical Engineering and Informatics, Osaka University,, 4. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University)

9:54 AM - 10:06 AM

[27J-am03] Development of effective cancer immunotherapy for the tumor with immunosuppressive tumor microenvironment

○Lisa Munakata¹, Taiki Aoshi², Shohei Koyama^3,4, Daiki Omata¹, Tamotsu Maruyama¹, Yuno Suzuki¹, Fumiko Hagiwara¹, Yoshiaki Okada⁵, Yasuo Yoshioka^2,5,6,7,8, Ryo Suzuki^1,9 (1. Fac. Pharma-Sci., Teikyo Univ., 2. RIMD, Osaka Univ., 3. Grad. Sch. Med., Osaka Univ., 4. NCC-EPOC, 5. Grad. Sch. Pharm. Sci., Osaka Univ., 6. OTRI, Osaka Univ., 7. BIKEN Foundation, Osaka Univ., 8. MEI, Osaka Univ., 9. ACRO, Teikyo Univ.)

10:06 AM - 10:18 AM

[27J-am04] Glioblastoma therapy with cisplatin delivery accelerated by ultrasound and microbubbles

○Daiki Omata¹, Fumiko Hagiwara¹, Lisa Munakata¹, Yuno Suzuki¹, Tamotsu Maruyama¹, Kazuo Maruyama^1,2, Ryo Suzuki^1,2 (1. Fac. Pharma-Sci., Teikyo Univ., 2. ACRO, Teikyo Univ.)

10:18 AM - 10:30 AM

[27J-am05S] Tumor-targeted ultrasonic-responsive nanodroplets

○Momoka Sasajima¹, Kenji Mishiro¹, Ryo Mizutani², Takeshi Fuchigami³, Kazuaki Ninomiya¹, Kazuma Ogawa^1,3 (1. Grad. Sch. Initiative., Kanazawa Univ., 2. Grad. Sch. Science., Kanazawa Univ., 3. Grad. Sch. Pharm., Kanazawa Univ.)

10:30 AM - 10:42 AM

[27J-am06S] Investigation of the distribution mechanism of intraperitoneally administered immune check point inhibitors to intraperitoneal tumors

○Mayu Yamamoto¹, Reiko Matsuda¹, Taiki Kurino¹, Yui Matsumoto¹, Hiroyuki Suzuki¹, Yu Sakurai², Hidetaka Akita^1,2, Tomoya Uehara¹, Akihiro Hisaka¹, Hiroto Hatakeyama¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ.)

Session information